NT21MP negatively regulates paclitaxel-resistant cells by targeting miR-155-3p and miR-155-5p via the CXCR4 pathway in breast cancer.
- Resource Type
- Article
- Source
- International Journal of Oncology; Sep2018, Vol. 53 Issue 3, p1043-1054, 12p
- Subject
- Language
- ISSN
- 10196439